Top

International Ophthalmology

Published in:

07-09-2022 | Vasculitis | Review

GSDMD-mediated pyroptosis in retinal vascular inflammatory diseases: a review

Authors: Li Xiaodong, Xie Xuejun

Published in: International Ophthalmology | Issue 4/2023

Abstract

Purpose

Pyroptosis is a newly discovered form of programmed pro-inflammatory cell death. The main signaling pathways include the classical scorch death pathway that depends on NLRP3 inflammatory vesicles and other activation caspase-1 and the non-classical scorch death pathway that depends on caspase-4 /5/11. The substrate of all inflammatory caspases is GSDMD; a large number of studies have confirmed that pyroptosis is associated with certain infectious diseases, atherosclerotic diseases, metabolic diseases, and aseptic inflammatory diseases of important organs. In recent years, pyroptosis has been studied partially in the ocular field. So, this article reviews the recent literature intending to help readers understand the main mechanisms of cellular scorch death and the progress of GSDMD-mediated cellular scorch death in retinal vascular inflammatory diseases.

Method

A detailed review of the literature related to pyroptosis and inflammatory diseases of the retinal vasculature is presented. The following 6 electronic databases were searched: CNKI, Wanfang, VIP, PubMed, The Cochrane Library, and Embase Databases, and the search period was from the database to May 2022. The main search keywords include “Pyroptosis,” “ GSDMD,” “Retinal Vascular Inflammatory Disease,” “Diabetic retinopathy,” “Retinal vasculitis.” The discovery of pyroptosis, the main molecular mechanisms, key proteins, and their pathogenesis and therapeutic prospects in retinal vasculitis diseases are extensively studied and summarized.

Result

The mechanisms of gasdermin D-mediated pyroptosis are elaborated and analyzed, with particular emphasis on their key role and potential in the pathogenesis and treatment of inflammatory retinal vascular lesions.

Conclusion

Gasdermin D-mediated pyroptosis is a well-studied form of programmed pro-inflammatory cell death, which has a bidirectional regulatory effect on a variety of immune and inflammatory diseases. The literature reveals that pyroptosis is closely related to the pathogenesis of retinal vascular inflammatory diseases, and it may be an important therapeutic target for diabetic retinopathy and other retinal vasculitis eye diseases in the future.

Cookson B, Brennan M (2001) Pro-inflammatory programmed cell death. Trends Microbiol 9(3):113–114CrossRefPubMed

Vande Walle L, Lamkanfi, (2016) Pyroptosis. Curr Bio 26(13):R568–R572CrossRef

Ross C, Chan A, von Pein J et al (2022) Inflammatory Caspases: Toward a Unified Model for Caspase Activation by Inflammasomes. Annu Rev Immunol 40:249–269CrossRefPubMed

Shi J, Zhao Y, Wang K et al (2015) Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death. Nature 526(7575):660–665CrossRefPubMed

Kesavardhana S, Malireddi R, Kanneganti TJAroi, (2020) Caspases in Cell Death, Inflammation, and Pyroptosis. Annu Rev Immunol 38:567–595CrossRefPubMedPubMedCentral

Rumpret Matevž, von Richthofen Helen J, Peperzak Victor et al (2022) Inhibitory pattern recognition receptors. J Experimet Med. https://doi.org/10.1084/jem.20211463CrossRef

Horvath G L, Schrum J E, De Nardo C M et al (2011) Intracellular sensing of microbes and danger signals by the inflammasomes: Inflammasome activation in inflammation. Immunological Reviews 243(1):119–135. https://doi.org/10.1111/j.1600-065X.2011.01050.xCrossRefPubMedPubMedCentral

Lu F, Lan Z, Xin Z et al (2020) Emerging insights into molecular mechanisms underlying pyroptosis and functions of inflammasomes in diseases. J Cell Physiol 235(4):3207–3221CrossRefPubMed

Man S M, Karki R, Kanneganti T-Devi (2017) Molecular mechanisms and functions of pyroptosis, inflammatory caspases and inflammasomes in infectious diseases. Immunol Rev 277(1):61–75. https://doi.org/10.1111/imr.12534CrossRefPubMedPubMedCentral

10.

Chen X, He W, Hu L et al (2016) Pyroptosis is driven by non-selective gasdermin-D pore and its morphology is different from MLKL channel-mediated necroptosis. Cell Res 26(9):1007–1020CrossRefPubMedPubMedCentral

11.

Kayagaki N, Wong M, Stowe I et al (2013) Noncanonical inflammasome activation by intracellular LPS independent of TLR4. Science 341(6151):1246–1249CrossRefPubMed

12.

Qiu S, Liu J, Xing F (2017) “Hints” in the killer protein gasdermin D: unveiling the secrets of gasdermins driving cell death. Cell death differs 24(4):588–596CrossRef

13.

Feng Shouya, Fox Daniel, Man Si Ming (2018) Mechanisms of Gasdermin Family Members in Inflammasome Signaling and Cell Death. J Molecul Biol 430(18):3068–3080. https://doi.org/10.1016/j.jmb.2018.07.002CrossRef

14.

Xia S (2020) Biological mechanisms and therapeutic relevance of the gasdermin family. Mol Aspects Med 76:100890CrossRefPubMedPubMedCentral

15.

Broz P (2015) Immunology: Caspase target drives pyroptosis. Nature 526(7575):642–643CrossRefPubMed

16.

Saeki N, Usui T, Aoyagi K et al (2009) Distinctive expression and function of four GSDM family genes (GSDMA-D) in normal and malignant upper gastrointestinal epithelium. Genes chromosomes cancer 48(3):261–271CrossRefPubMed

17.

Burgener S, Leborgne N, Snipas S et al (2019) Cathepsin G Inhibition by Serpinb1 and Serpinb6 Prevents Programmed Necrosis in Neutrophils and Monocytes and Reduces GSDMD-Driven Inflammation. Cell Rep 27(12):3646-3656.e3645CrossRefPubMedPubMedCentral

18.

Kambara H, Liu F, Zhang X et al (2018) Gasdermin D Exerts Anti-inflammatory Effects by Promoting Neutrophil Death. Cell Rep 22(11):2924–2936CrossRefPubMedPubMedCentral

19.

Xi G, Gao J, Wan B et al (2019) GSDMD is required for effector CD8 T cell responses to lung cancer cells. Int Immunopharmacol 74:105713CrossRefPubMed

20.

Liu X, Zhang Z, Ruan J et al (2016) Inflammasome-activated gasdermin D causes pyroptosis by forming membrane pores. Nature 535(7610):153–158CrossRefPubMedPubMedCentral

21.

Liu Z, Wang C, Rathkey J et al (2018) Structures of the Gasdermin D C-Terminal Domains Reveal Mechanisms of Autoinhibition. Structure 26(5):778-784.e773CrossRefPubMedPubMedCentral

22.

Liu Z, Wang C, Yang J et al (2019) Crystal Structures of the Full-Length Murine and Human Gasdermin D Reveal Mechanisms of Autoinhibition, Lipid Binding, and Oligomerization. Immunity 51(1):43-49.e44CrossRefPubMedPubMedCentral

23.

Ding J, Wang K, Liu W et al (2016) Erratum: Pore-forming activity and structural autoinhibition of the gasdermin family. Nature 540(7631):150CrossRefPubMed

24.

Teng Jin-Feng, Mei Qi-Bing, Zhou Xiao-Gang et al (2020) Polyphyllin VI Induces Caspase-1-Mediated Pyroptosis via the Induction of ROS/NF-κB/NLRP3/GSDMD Signal Axis in Non-Small Cell Lung Cancer. Cancers 12(1):193. https://doi.org/10.3390/cancers12010193CrossRefPubMedPubMedCentral

25.

Rathkey J, Zhao J, Liu Z, et al (2018) Chemical disruption of the pyroptotic pore-forming protein gasdermin D inhibits inflammatory cell death and sepsis. Sci Immunol, 3(26).

26.

Bansal N, Sciabola S, Bhisetti G (2019) Understanding allosteric interactions in hMLKL protein that modulate necroptosis and its inhibition. Sci Rep 9(1):16853CrossRefPubMedPubMedCentral

27.

Feenstra D, Yego E, Mohr S (2013) Modes of Retinal Cell Death in Diabetic Retinopathy. J Clin Exp Ophthalmol 4(5):298PubMedPubMedCentral

28.

Petersen L, Bek T (2019) The Oxygen Saturation in Vascular Abnormalities Depends on the Extent of Arteriovenous Shunting in Diabetic Retinopathy. Invest Ophthalmol Vis Sci 60(12):3762–3767CrossRefPubMed

29.

Simó R, Hernández C, (2014) Neurodegeneration in the diabetic eye: new insights and therapeutic perspectives .Trends Endocrinol Metab , 25(1):23–33.

30.

Ferrington DA, Fisher CR, Kowluru RA (2020) Mitochondrial Defects Drive Degenerative Retinal Diseases. Trends Mol Med 26(1):105–118CrossRefPubMed

31.

Chai G, Liu S, Yang H et al (2020) NLRP3 Blockade Suppresses Pro-Inflammatory and Pro-Angiogenic Cytokine Secretion in Diabetic Retinopathy. Diabetes, metabolic syndrome, and obesity: targets and therapy 13:3047–3058CrossRefPubMed

32.

Loukovaara S, Piippo N, Kinnunen K et al (2017) NLRP3 inflammasome activation is associated with proliferative diabetic retinopathy. Acta Ophthalmol 95(8):803–808CrossRefPubMed

33.

Yin Y, Chen F, Wang W et al (2017) Resolvin D1 inhibits inflammatory response in STZ-induced diabetic retinopathy rats: Possible involvement of NLRP3 inflammasome and NF-κB signaling pathway. Mol Vis 23:242–250PubMedPubMedCentral

34.

Zhang Y, Lv X, Hu Z et al (2017) Protection of Mcc950 against high-glucose-induced human retinal endothelial cell dysfunction. Cell Death Dis 8(7):e2941CrossRefPubMedPubMedCentral

35.

Solini A, Novak I (2019) Role of the P2X7 receptor in the pathogenesis of type 2 diabetes and its microvascular complications. Curr Opin Pharmacol 47:75–81CrossRefPubMed

36.

Lu L, Lu Q, Chen W et al (2018) Vitamin D Protects against Diabetic Retinopathy by Inhibiting High-Glucose-Induced Activation of the ROS/TXNIP/NLRP3 Inflammasome Pathway. J Diabetes Res 2018:8193523CrossRefPubMedPubMedCentral

37.

Liu Q, Zhang F, Zhang X et al (2018) Fenofibrate ameliorates diabetic retinopathy by modulating Nrf2 signaling and NLRP3 inflammasome activation. Mol Cell Bio 445:105–115

38.

Sun H, Jin X, Xu J et al (2020) Baicalin Alleviates Age-Related Macular Degeneration via miR-223/NLRP3-Regulated Pyroptosis. Pharmacol 105:28–38CrossRef

39.

Yu X, Ma X, Lin W, et al(2020)Long noncoding RNA MIAT regulates primary human retinal pericyte pyroptosis by modulating miR-342–3p targeting of CASP1 in diabetic retinopathy. Exp Eye Res:108300.

40.

Datoo GA, O’Keefe N R (2021) Retinal vasculitis: A framework and proposal for a classification system. Survey of Ophthalmology 66(1):54–67. https://doi.org/10.1016/j.survophthal.2020.05.004CrossRef

41.

Rosenbaum J, Sibley C, Lin P (2016) Retinal vasculitis. Cur Opinion. Rheumatol 28(3):228–235

42.

Sui A, Chen X, Shen J et al (2020) Inhibiting the NLRP3 inflammasome with MCC950 ameliorates retinal neovascularization and leakage by reversing the IL-1β/IL-18 activation pattern in an oxygen-induced ischemic retinopathy mouse model. Cell Death Dis 11(10):901CrossRefPubMedPubMedCentral

Title: GSDMD-mediated pyroptosis in retinal vascular inflammatory diseases: a review
Authors: Li Xiaodong
Xie Xuejun
Publication date: 07-09-2022
Publisher: Springer Netherlands
Keywords: Vasculitis
Vasculitis
Diabetic Retinopathy
Diabetic Retinopathy
Published in: International Ophthalmology / Issue 4/2023
Print ISSN: 0165-5701
Electronic ISSN: 1573-2630
DOI: https://doi.org/10.1007/s10792-022-02506-z

Keynote webinar | Spotlight on medication adherence

Springer Medicine

GSDMD-mediated pyroptosis in retinal vascular inflammatory diseases: a review

Abstract

Purpose

Method

Result

Conclusion

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Purpose

Method

Result

Conclusion

Please log in to get access to this content

Other articles of this Issue 4/2023

Prevalence of Demodex folliculorum and Demodex brevis in patients with blepharitis and chalazion

Refractive surgery after deep anterior lamellar keratoplasty: a review of the literature

Pars-plana-vitrectomy for endophthalmitis treatment and the role of standardized ultrasound

Double peak axial length measurement signal in cataract patients with epiretinal membrane

Association between tear meniscus dimensions and higher-order aberrations in patients with surgically treated lacrimal passage obstruction

miR-125a-3p regulates apoptosis by suppressing TMBIM4 in lens epithelial cells